Key Points:
- Uruguay’s Ministry of Health is considering a decree to ban nicotine pouches.
- The issue was raised at the Mercosur Tobacco Control Commission ahead of COP11.
- Health Minister says new nicotine products increase addiction risk in youth.
- Nicotine pouches already circulate through travel and online purchases.
- Authorities warn of low risk perception among young people regarding new nicotine products.
2Firsts, November 20, 2025 — According to El Observador, nicotine pouches—marketed as pleasant in the mouth, fresh-flavored, and free of the lung harm associated with smoking—have begun circulating in Uruguay. A tin of 15 pouches costs about 800 Uruguayan pesos, and although not widely available in shops, they are easily found online. As with e-cigarettes, nicotine pouches divide opinion worldwide: some frame them as an alternative to combustible cigarettes, while health authorities warn they are equally or more addictive.
Sources in the Ministry of Public Health said the government is evaluating a decree to prohibit nicotine pouches. Although the product is not officially sold in Uruguay, it is already being used by consumers who bring it from abroad or source it online, prompting authorities to consider early intervention.
Two months ago, Uruguay raised the issue at the Mercosur Intergovernmental Tobacco Control Commission, ahead of COP11 negotiations. Uruguay’s representative, Cecilia Reolón of the Tobacco Control Program, expressed concern about nicotine pouches entering the national market and told partners that such products “must be regulated or prohibited by governments.” She also highlighted the need to strengthen oversight of online tobacco sales and advertising.
After the first day of COP11 in Geneva, Health Minister Cristina Lustemberg said the tobacco industry was promoting new products “to normalize consumption,” stressing that evidence is clear that these products are “not harmless and increase addiction among children and adolescents.” She noted that Uruguay “fully restored the ban on electronic cigarettes” to prevent a surge in youth vaping.
The ministry said the new government has reversed two decrees issued under former president Luis Lacalle Pou that relaxed packaging and heated-tobacco rules, reinforcing regulation so that heated-tobacco products and e-liquid vapes now fall under identical standards.
The American Lung Association warns of strong addiction potential, while some harm-reduction groups argue that switching to smokeless products could avoid most respiratory deaths from combustible tobacco.
CDC data show that in 2022, about 3% of U.S. adults reported using nicotine pouches, with 0.4% being frequent users; in 2024, about 2% of high-school students reported current use. Meanwhile, media outlets such as Forbes and Reuters report that tobacco companies are pressuring the Trump administration to speed up FDA authorizations.
Although Uruguay lacks specific studies on nicotine pouches, the Ministry of Health notes a low risk perception among youth regarding e-cigarettes, due in part to colorful and high-tech designs and strong social-media promotion, despite domestic advertising bans. Official data also show a plateau in tobacco-use prevalence, underscoring the need to address new nicotine-delivery trends.
Online searches for “bolsas de nicotina” yield various sellers, offering brands such as ZYN, Velo, Kadobar, Tacha, Pablo and Fre for 750 to 800 pesos.
Image Source: El Observador
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
